ELVAF
EvoNext Holdings SA engages in the business of researching, developing, and commercializing novel nutritional, healthcare, and wellness ingredients. The company was founded by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith in 2004 and is headquartered in Reinach, Switzerland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | -0.04 | $0 | — |
| 2025 Q2 | -0.05 | $0 | -$440,300 |
| 2024 Q4 | -0.07 | $0 | -$588,400 |
| 2024 Q2 | 0.19 | $0 | -$2M |
| 2023 Q4 | -2.18 | $5M | $3M |
| 2023 Q2 | -17.60 | $4M | -$6M |
| 2022 Q4 | -3.25 | $7M | -$6M |
| 2022 Q2 | -6.55 | $8M | -$15M |